Work

Supplementary Data from Tumor Survivin Is Downregulated by the Antisense Oligonucleotide LY2181308: A Proof-of-Concept, First-in-Human Dose Study

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figures S1-S2.
Language: English
Open Access status: gold
OpenAlex ID: W4361880561
Cites:
Cited by:
Related to: 10